# Skydance Corp: financial statements, quarterly

SKYD · NYSE · CIK 2041610 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/skyd.md) · [Financials](/companies/skyd/financials.md) · [Filings](/companies/skyd/filings.md) · [Insiders](/companies/skyd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/skyd/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,731](/filings/0002041610-25-000044.md) | [7,984 d](/filings/0002041610-26-000011.md) | [7,192](/filings/0002041610-26-000026.md) | [6,849](/filings/0002041610-26-000054.md) | [7,347](/filings/0002041610-26-000026.md) | [6,913](/filings/0002041610-26-000054.md) |
| Selling, general and administrative | $m | [1,531](/filings/0002041610-25-000044.md) | [1,886 d](/filings/0002041610-26-000011.md) | [1,543](/filings/0002041610-26-000026.md) | [1,401](/filings/0002041610-26-000054.md) | [1,411](/filings/0002041610-26-000026.md) | [1,443](/filings/0002041610-26-000054.md) |
| Operating income | $m | [337](/filings/0002041610-25-000044.md) | [129 d](/filings/0002041610-26-000011.md) | [550](/filings/0002041610-26-000026.md) | [399](/filings/0002041610-26-000054.md) | [616](/filings/0002041610-26-000026.md) | [475](/filings/0002041610-26-000054.md) |
| Interest expense | $m | [209](/filings/0002041610-25-000044.md) | [215 d](/filings/0002041610-26-000011.md) | [217](/filings/0002041610-26-000026.md) | [214](/filings/0002041610-26-000054.md) | [238](/filings/0002041610-26-000026.md) | [255](/filings/0002041610-26-000054.md) |
| Income tax | $m | [45.0](/filings/0002041610-25-000044.md) | [37.0 d](/filings/0002041610-26-000011.md) | [100](/filings/0002041610-26-000026.md) | [50.0](/filings/0002041610-26-000054.md) | [155](/filings/0002041610-26-000026.md) | [120](/filings/0002041610-26-000054.md) |
| Net income | $m | [1.0](/filings/0002041610-25-000044.md) | [(224) d](/filings/0002041610-26-000011.md) | [152](/filings/0002041610-26-000026.md) | [57.0](/filings/0002041610-26-000054.md) | [168](/filings/0002041610-26-000026.md) | [41.0](/filings/0002041610-26-000054.md) |
| Diluted EPS | $ per share | [0.00](/filings/0002041610-25-000044.md) | not reported | [0.22](/filings/0002041610-26-000026.md) | [0.08](/filings/0002041610-26-000054.md) | [0.15](/filings/0002041610-26-000026.md) | [0.04](/filings/0002041610-26-000054.md) |
| Basic EPS | $ per share | [0.00](/filings/0002041610-25-000044.md) | not reported | [0.23](/filings/0002041610-26-000026.md) | [0.08](/filings/0002041610-26-000054.md) | [0.15](/filings/0002041610-26-000026.md) | [0.04](/filings/0002041610-26-000054.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-06-03) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | period not labelled (2025-08-06) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | [2.7](/filings/0002041610-26-000011.md) | not reported | not reported | not reported | [3.3](/filings/0002041610-25-000044.md) | [3.3](/filings/0002041610-26-000054.md) | [1.9](/filings/0002041610-26-000026.md) | [1.6](/filings/0002041610-26-000054.md) |
| Current assets | $bn | not reported | not reported | not reported | not reported | [12.5](/filings/0002041610-26-000011.md) | [0.0](/filings/0002041610-25-000010.md) | [0.0](/filings/0002041610-25-000013.md) | not reported | [13.2](/filings/0002041610-25-000044.md) | [13.3](/filings/0002041610-26-000054.md) | [11.6](/filings/0002041610-26-000026.md) | [11.0](/filings/0002041610-26-000054.md) |
| Total assets | $bn | not reported | not reported | not reported | not reported | [46.2](/filings/0002041610-26-000011.md) | [0.0](/filings/0002041610-25-000010.md) | [0.0](/filings/0002041610-25-000013.md) | not reported | [43.2](/filings/0002041610-25-000044.md) | [43.3](/filings/0002041610-26-000054.md) | [44.5](/filings/0002041610-26-000026.md) | [44.4](/filings/0002041610-26-000054.md) |
| Current liabilities | $bn | not reported | not reported | not reported | not reported | [9.6](/filings/0002041610-26-000011.md) | [0.0](/filings/0002041610-25-000010.md) | [0.0](/filings/0002041610-25-000013.md) | not reported | [9.9](/filings/0002041610-25-000044.md) | [10.6](/filings/0002041610-26-000054.md) | [10.5](/filings/0002041610-26-000026.md) | [10.6](/filings/0002041610-26-000054.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | [0.0](/filings/0002041610-26-000011.md) | not reported | not reported | not reported | [0.0](/filings/0002041610-25-000044.md) | [0.0](/filings/0002041610-26-000054.md) | [0.0](/filings/0002041610-26-000026.md) | [0.0](/filings/0002041610-26-000054.md) |
| Shareholders' equity | $bn | [23.1](/filings/0002041610-26-000011.md) | [0.0](/filings/0002041610-25-000013.md) | [0.0](/filings/0002041610-25-000013.md) | [17.1](/filings/0002041610-25-000044.md) | [16.3](/filings/0002041610-26-000011.md) | [0.0](/filings/0002041610-25-000013.md) | [0.0](/filings/0002041610-25-000013.md) | [17.3](/filings/0002041610-26-000011.md) | [12.0](/filings/0002041610-25-000044.md) | [11.7](/filings/0002041610-26-000054.md) | [11.7](/filings/0002041610-26-000026.md) | [11.8](/filings/0002041610-26-000054.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [168 d](/filings/0002041610-26-000011.md) | [180](/filings/0002041610-26-000026.md) | [159 d](/filings/0002041610-26-000054.md) | [185](/filings/0002041610-26-000026.md) | [319 d](/filings/0002041610-26-000054.md) |
| Capital expenditure | $m | [112 d](/filings/0002041610-26-000011.md) | [57.0](/filings/0002041610-26-000026.md) | [45.0 d](/filings/0002041610-26-000054.md) | [89.0](/filings/0002041610-26-000026.md) | [61.0 d](/filings/0002041610-26-000054.md) |
| Dividends paid | $m | [37.0 d](/filings/0002041610-26-000011.md) | [36.0](/filings/0002041610-26-000026.md) | [34.0 d](/filings/0002041610-26-000054.md) | [61.0](/filings/0002041610-26-000026.md) | [56.0 d](/filings/0002041610-26-000054.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [670](/filings/0002041610-25-000044.md) | [678](/filings/0002041610-26-000026.md) | [680](/filings/0002041610-26-000054.md) | [1,118](/filings/0002041610-26-000026.md) | [1,120](/filings/0002041610-26-000054.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,071,666,977 at 2025-11-05, from the cover of the [10-Q filed 2025-11-10](/filings/0002041610-25-000044.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.